<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01960751</url>
  </required_header>
  <id_info>
    <org_study_id>C13-01</org_study_id>
    <secondary_id>2013-A00513-42</secondary_id>
    <nct_id>NCT01960751</nct_id>
  </id_info>
  <brief_title>Long Term Neurocognitive Effects of Low-dose Radiation in the Brain: Study of 150 Patients in the French Hemangioma Cohort</brief_title>
  <acronym>CogRad</acronym>
  <official_title>Etude Des séquelles Neurocognitives à Long Terme Des Faibles Doses de Radiation Chez 150 Patients traités Par radiothérapie Dans l'Enfance Pour un hémangiome cutané à l'Institut Gustave Roussy (IGR) Entre 1941 et 1973</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gustave Roussy, Cancer Campus, Grand Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Context: Studies that address specifically the neurocognitive consequences that can be caused
      by low-dose radiation receiving during the childhood have still to be performed. In this
      issue, we focus on an investigation with patients who have received radiotherapy for a benign
      tumor (skin hemangioma), in France.

      Patients and methods: More than 8300 children with a skin hemangioma were treated at Gustave
      Roussy (Île-de-France) from 1941 to 1973 and a number of them have received radiotherapy.
      These patients have been treated and followed by Gustave Roussy, so their clinical records
      can be tracked with great accuracy and the ionizing radiation dose to the brain have been
      estimated. From this patient cohort, the aim is to evaluate neurocognitive dysfunction or
      disorder that can be caused by low-dose radiation to the brain (less than one Gray (Gy)). A
      total of 150 patients is expected. They will be contacted by letter to explain the purpose
      and methods of carrying out tests. Two groups will be analysed according to the received
      ionizing radiation dose to the brain during the radiotherapy (exposed: 0.05 to 1 Gy, vs
      unexposed: less than 0.05 Gy). Tests exploring several cognitive functions (memory,
      arithmetic, orientation, etc.) will be used.

      Expected results: We expect to describe the potential neurocognitive dysfunction or disorder
      and to identify risk factors and brain structures whose lesions are responsible for the
      neurocognitive dysfunction or disorder.

      A therapeutic treatment will be proposed in the eventuality of screening of a neurocognitive
      dysfunction or disorder.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CogRad is an interventional study designed within the European project called Cognitive and
      Cerebrovascular Effects Induced by Low Dose Ionizing Radiation (CerebRad).

      CerebRad is a collaborative European project funded in 2011 within the 7th European Union
      (EU) framework programme, Nuclear Fission and Radiation Protection. CerebRad aims to identify
      the potential cognitive and cerebrovascular risks of radiation doses below 100 milliGray
      (mGy) when delivered to a young child (pre- or postnatally).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All neurocognitive dysfunction or disorder on adults measured by means of eight tests</measure>
    <time_frame>Participants will be tested for the duration of hospital stay (half a day).The neurocognitive tests battery will be carry out 56 years on average after exposure to low-dose radiation.</time_frame>
    <description>The score to the 8 tests will be correlate with the presence of neurocognitive dysfunction or disorder</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Patients Treated by Radiotherapy With &lt; One Gy to the Brain</condition>
  <arm_group>
    <arm_group_label>neurocognitive tests</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>neurocognitive tests battery (MMSE, SDS, SF-36, HAD, BPRS, RAVLT, FACT-Cog, MoCA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>neurocognitive tests battery</intervention_name>
    <description>The two groups (exposed: 0.05 to 1 Gy; unexposed: less than 0.05 Gy) will receive the same neurocognitive tests battery.</description>
    <arm_group_label>neurocognitive tests</arm_group_label>
    <other_name>- MMSE</other_name>
    <other_name>- SDS</other_name>
    <other_name>- SF-36</other_name>
    <other_name>- HAD</other_name>
    <other_name>- BPRS</other_name>
    <other_name>- RAVLT</other_name>
    <other_name>- FACT-Cog</other_name>
    <other_name>- MoCA</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject treated by radiotherapy for a skin hemangioma in childhood at Gustave Roussy
             between 1941 and 1973 and who have received less than 1 Gy of radiation doses in the
             brain

          -  Inhabitants of Île-de-France

          -  French medical insurance

          -  Good knowledge and understanding of the French language

        Non-inclusion Criteria

          -  Cerebral hemangioma

          -  Syndrome genetic predisposition

          -  Pregnant woman

          -  Private person of liberty or under guardianship

          -  Radiation dose to the brain greater than 1 Gy during radiotherapy treatment of skin
             hemangioma

          -  Chemotherapy during skin hemangioma treatment

          -  Inability to undergo counseling for geographical reasons

        Exclusion Criteria:

          -  Pregnancy

          -  Inability to perform neurocognitive tests battery for medical reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chiraz EL-FAYECH</last_name>
    <role>Study Director</role>
    <affiliation>Gustave Roussy, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Florent DE VATHAIRE</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chiraz EL-FAYECH</last_name>
    <email>chiraz.fayech@gustaveroussy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie NYS</last_name>
    <email>julie.nys@gustaveroussy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Isabelle LEGER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie KIEFFER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole RUBINO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile THOMAS-TEINTURIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.cerebrad-fp7.eu/</url>
    <description>Click here for more information about CerebRad, the collaborative European project funded in 2011 within the 7th EU framework programme.</description>
  </link>
  <reference>
    <citation>Fragu P, Lemarchand-Venencie F, Benhamou S, François P, Jeannel D, Benhamou E, Sezary-Lartigau I, Avril MF. Long-term effects in skin and thyroid after radiotherapy for skin angiomas: a French retrospective cohort study. Eur J Cancer. 1991;27(10):1215-22.</citation>
    <PMID>1835589</PMID>
  </reference>
  <reference>
    <citation>Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988 Oct 20;319(16):1033-9.</citation>
    <PMID>3173432</PMID>
  </reference>
  <reference>
    <citation>Little MP, Hawkins MM, Shore RE, Charles MW, Hildreth NG. Time variations in the risk of cancer following irradiation in childhood. Radiat Res. 1991 Jun;126(3):304-16. Erratum in: Radiat Res 1992 Oct;132(1):126.</citation>
    <PMID>2034788</PMID>
  </reference>
  <reference>
    <citation>Hall P, Adami HO, Trichopoulos D, Pedersen NL, Lagiou P, Ekbom A, Ingvar M, Lundell M, Granath F. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ. 2004 Jan 3;328(7430):19.</citation>
    <PMID>14703539</PMID>
  </reference>
  <reference>
    <citation>Haddy N, Andriamboavonjy T, Paoletti C, Dondon MG, Mousannif A, Shamsaldin A, Doyon F, Labbé M, Robert C, Avril MF, Fragu P, Eschwege F, Chavaudra J, Schvartz C, Lefkopoulos D, Schlumberger M, Diallo I, de Vathaire F. Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy. Radiother Oncol. 2009 Nov;93(2):377-82. doi: 10.1016/j.radonc.2009.05.011. Epub 2009 Jun 8.</citation>
    <PMID>19515442</PMID>
  </reference>
  <reference>
    <citation>Haddy N, Mousannif A, Paoletti C, Dondon MG, Shamsaldin A, Doyon F, Avril MF, Fragu P, Labbé M, Lefkopoulos D, Chavaudra J, Robert C, Diallo I, de Vathaire F. Radiotherapy as a risk factor for malignant melanoma after childhood skin hemangioma. Melanoma Res. 2012 Feb;22(1):77-85. doi: 10.1097/CMR.0b013e32834dcff1.</citation>
    <PMID>22082956</PMID>
  </reference>
  <reference>
    <citation>Haddy N, Dondon MG, Paoletti C, Rubino C, Mousannif A, Shamsaldin A, Doyon F, Labbé M, Robert C, Avril MF, Demars R, Molinie F, Lefkopoulos D, Diallo I, de Vathaire F. Breast cancer following radiotherapy for a hemangioma during childhood. Cancer Causes Control. 2010 Nov;21(11):1807-16. doi: 10.1007/s10552-010-9607-5. Epub 2010 Jul 7.</citation>
    <PMID>20607383</PMID>
  </reference>
  <reference>
    <citation>Dondon MG, de Vathaire F, Shamsaldin A, Doyon F, Diallo I, Ligot L, Paoletti C, Labbé M, Abbas M, Chavaudra J, Avril MF, Fragu P, Eschwège F. Cancer mortality after radiotherapy for a skin hemangioma during childhood. Radiother Oncol. 2004 Jul;72(1):87-93.</citation>
    <PMID>15236880</PMID>
  </reference>
  <reference>
    <citation>Ligot L, Diallo I, Shamsaldin A, Chavaudra J, BonaIti-Pellié C, de Vathaire F. Individualized phantom based on CT slices and auxological data (ICTA) for dose estimations following radiotherapy for skin haemangioma in childhood. Radiother Oncol. 1998 Dec;49(3):279-85.</citation>
    <PMID>10075261</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2013</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2013</study_first_posted>
  <last_update_submitted>October 8, 2013</last_update_submitted>
  <last_update_submitted_qc>October 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

